Approval · Notice of Compliance 24709 · 2020
LYDAXX: Notice of Compliance 24709
Issued December 1, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24709
- Date
- December 1, 2020
- Company
- Vetoquinol N A IncLavaltrie, Quebec, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DRAXXIN (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LYDAXX | 02508990 | Marketed |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML